Daniel E. Frigo

Dr. Daniel E. Frigo is a tenured Professor and Deputy Department Chair in the Department of Cancer Systems Imaging at The University of Texas MD Anderson Cancer Center, Houston, TX. He holds dual appointments as Professor in the Department of Genitourinary Medical Oncology (Division of Cancer Medicine) at MD Anderson and maintains adjunct roles as Professor at the University of Houston’s Center for Nuclear Receptors & Cell Signaling and Department of Biology & Biochemistry. His research focuses on understanding the basic biology of prostate cancer to develop novel therapies for advanced stages of the disease.

Education & Training: B.S. in Biochemistry (University of Notre Dame), Ph.D. in Molecular and Cellular Biology (Tulane University), Postdoctoral Fellowship at Duke University Medical Center (Durham, NC). Faculty appointment began at the University of Houston in 2010 before relocating his laboratory to MD Anderson in 2017.

Research Interests: Dr. Frigo’s work integrates molecular oncology, signaling pathways, and drug discovery to address prostate cancer progression. His lab explores mechanisms driving treatment resistance and metastasis, emphasizing translational approaches to clinical applications.

Grants & Advising: Active in securing grants and mentoring trainees, though specific grant details and student names are not listed in the provided text. His CV highlights ongoing contributions to cancer research and clinical trials at MD Anderson.